CO5080803A1 - Proceso de preparacion de 4-substituido-1h-indol-3-glioxami- das - Google Patents

Proceso de preparacion de 4-substituido-1h-indol-3-glioxami- das

Info

Publication number
CO5080803A1
CO5080803A1 CO99022895A CO99022895A CO5080803A1 CO 5080803 A1 CO5080803 A1 CO 5080803A1 CO 99022895 A CO99022895 A CO 99022895A CO 99022895 A CO99022895 A CO 99022895A CO 5080803 A1 CO5080803 A1 CO 5080803A1
Authority
CO
Colombia
Prior art keywords
formula
compound
jpeg
mfi
emi file
Prior art date
Application number
CO99022895A
Other languages
English (en)
Inventor
Benjamin Alan Anderson
Nancy Kay Harn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CO5080803A1 publication Critical patent/CO5080803A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un proceso de preparación de un compuesto de la fórmula I o una sal o prodroga derivada del mismo farmacéuticamente aceptable<EMI FILE="99022895_1" ID="1" IMF=JPEG >En donde:R1 es seleccionado del grupo que consiste de alquilo C7-C20;<EMI FILE="99022895_2" ID="2" IMF=JPEG >donde;R10 es seleccionado del grupo que consiste de halo, alquilo C1-C10, alcoxi C1-C10, -S-(aquil C1-C10) y halo alquilo C1-C10 y t es un entero entre 0 y 5 ambos incluidos; R2 es seleccionado del grupo que consiste de hidrógeno, halo, alquilo C1-C3, cicloalquilo C3-C4, cicloalquenilo C3-C4, -O-(alquil C1-C2), -S-(alquilo C1-C2), aril, ariloxi, y HET corresponde a un anillo heterocíclico que incluye piridina, pirazina, pirimidina, piridazina, pirazol, furano, tiofeno, tiofeno, tiazol, isotiazol, oxadiazol, imidazol, triazol y tetrazol;R4 es seleccionado del grupo que consiste de -CO2H, -SO3H, y -P(O)(OH)2 o una sal o prodroga derivadas del mismo; yR5 es seleccionado del grupo que consiste de hidrógeno, alquilo (C1-C6), alcoxi (C1-C6), halo alcoxi(C1-C6), halo alquil (C1-C6), bromo, cloro, flúor, yodo y arilo;Proceso que comprende los siguientes pasos:a) Halogenación de un compuesto de fórmula X<EMI FILE="99022895_3" ID="3" IMF=JPEG >En donde R8 es alquil (C1-C6), arilo o HET, en donde HET corresponde a un anillo heterocíclico que incluye piridina, pirazina, pirimidina, piridazina, pirrol, pirazol, furano, tiofeno, tiazol, isotiazol, oxadiazol, tiadiazol, imidazol, triazol y tetrazol;Con SO2Cl2 para formar un compuesto de fórmula IX<EMI FILE="99022895_4" ID="4" IMF=JPEG >b) Hidrolización y descarboxilación de un compuesto de fórmula IX<EMI FILE="99022895_5" ID="5" IMF=JPEG >- 2 -- 2 -Para formar un compuesto de fórmula VIII<EMI FILE="99022895_6" ID="6" IMF=JPEG >c) Alquilación de un compuesto de fórmula VII<EMI FILE="99022895_7" ID="7" IMF=JPEG >Con un compuesto de fórmula VIII<EMI FILE="99022895_8" ID="8" IMF=JPEG >Para formar un compuesto de fórmula VI<EMI FILE="99022895_9" ID="9" IMF=JPEG >d) Aminación y deshidratación de un compuesto de fórmula VI<EMI FILE="99022895_10" ID="10" IMF=JPEG >Con una amina de la fórmula R1NH2 en presencia de un solvente que formar un azeótropo con agua para formar un compuesto de formula V<EMI FILE="99022895_11" ID="11" IMF=JPEG >e) Oxidación de un compuesto de fórmula V<EMI FILE="99022895_12" ID="12" IMF=JPEG >Por el calentamiento por una base y un reactivo sulfinilante de la fórmula RSOX donde R es alquilo-( C1-C6) o arilo y X es alcoxi (C1-C6), halo, o -OCO2 alquilo(C1-C6) para formar un compuesto de fórmula IV<EMI FILE="99022895_13" ID="13" IMF=JPEG >f) Alquilación de un compuesto de fórmula IV<EMI FILE="99022895_14" ID="14" IMF=JPEG >con un agente alquilante de la fórmula XCH2R4a donde X es un grupo saliente y R4a es -CO2R4b , -SO3R4b , -P(O)(OR4b)2, o -P(O)(OR4b)H, donde R4b es un grupo protector ácido, para formar un compuesto de fórmula III<EMI FILE="99022895_15" ID="15" IMF=JPEG >g) Reacción de un compuesto de fórmula III<EMI FILE="99022895_16" ID="16" IMF=JPEG >con cloruro de oxalil y amoniaco para formar un compuesto de fórmula II<EMI FILE="99022895_17" ID="17" IMF=JPEG >h) Opcionalmente, hidrolización de un compuesto de fórmula II<EMI FILE="99022895_18" ID="18" IMF=JPEG >Para formar un compuesto de fórmula I; yi) Opcionalmente, salificación de un compuesto de fórmula I.
CO99022895A 1998-04-17 1999-04-16 Proceso de preparacion de 4-substituido-1h-indol-3-glioxami- das CO5080803A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8211098P 1998-04-17 1998-04-17

Publications (1)

Publication Number Publication Date
CO5080803A1 true CO5080803A1 (es) 2001-09-25

Family

ID=22169126

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99022895A CO5080803A1 (es) 1998-04-17 1999-04-16 Proceso de preparacion de 4-substituido-1h-indol-3-glioxami- das

Country Status (27)

Country Link
US (1) US6265591B1 (es)
EP (1) EP1071663A4 (es)
JP (1) JP2002512225A (es)
KR (1) KR20010042741A (es)
CN (1) CN1305459A (es)
AR (1) AR015767A1 (es)
AU (1) AU750368B2 (es)
BR (1) BR9909697A (es)
CA (1) CA2326515A1 (es)
CO (1) CO5080803A1 (es)
DZ (1) DZ2770A1 (es)
EA (1) EA003582B1 (es)
EG (1) EG22139A (es)
HK (1) HK1039120A1 (es)
HR (1) HRP20000685A2 (es)
HU (1) HUP0101344A3 (es)
ID (1) ID26021A (es)
IL (1) IL138827A0 (es)
NO (1) NO20005148L (es)
NZ (1) NZ507175A (es)
PE (1) PE20000430A1 (es)
PL (1) PL343487A1 (es)
SK (1) SK15372000A3 (es)
SV (1) SV1999000043A (es)
TR (1) TR200002999T2 (es)
WO (1) WO1999054300A1 (es)
ZA (1) ZA200005294B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1071661A4 (en) * 1998-04-17 2001-08-22 Lilly Co Eli METHOD FOR PRODUCING 4-HYDROXYINDOL, INDAZOL AND CARBAZOL COMPOUNDS
US6407261B1 (en) 1998-04-17 2002-06-18 Eli Lilly And Company Process for preparing 4-hdyroxy indole, indazole and carbazole compounds
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
US20030225149A1 (en) * 2002-04-30 2003-12-04 Blazecka Peter G. Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
AR088377A1 (es) 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY112897A (en) 1994-04-01 2001-10-31 Lilly Co Eli Ih-indole-3-glyoxylamide spla2 inhibitors
EP1071661A4 (en) * 1998-04-17 2001-08-22 Lilly Co Eli METHOD FOR PRODUCING 4-HYDROXYINDOL, INDAZOL AND CARBAZOL COMPOUNDS

Also Published As

Publication number Publication date
ZA200005294B (en) 2001-10-01
HRP20000685A2 (en) 2001-10-31
SV1999000043A (es) 2000-05-02
CA2326515A1 (en) 1999-10-28
EG22139A (en) 2002-08-30
WO1999054300A1 (en) 1999-10-28
EA200001076A1 (ru) 2001-04-23
PE20000430A1 (es) 2000-05-24
CN1305459A (zh) 2001-07-25
PL343487A1 (en) 2001-08-27
EP1071663A1 (en) 2001-01-31
AU3564899A (en) 1999-11-08
BR9909697A (pt) 2000-12-19
NO20005148D0 (no) 2000-10-13
EA003582B1 (ru) 2003-06-26
AR015767A1 (es) 2001-05-16
AU750368B2 (en) 2002-07-18
IL138827A0 (en) 2001-10-31
TR200002999T2 (tr) 2001-01-22
KR20010042741A (ko) 2001-05-25
DZ2770A1 (fr) 2003-12-01
NO20005148L (no) 2000-11-09
EP1071663A4 (en) 2002-06-19
HUP0101344A2 (hu) 2001-09-28
NZ507175A (en) 2002-12-20
US6265591B1 (en) 2001-07-24
HUP0101344A3 (en) 2002-12-28
ID26021A (id) 2000-11-16
JP2002512225A (ja) 2002-04-23
HK1039120A1 (zh) 2002-04-12
SK15372000A3 (sk) 2001-08-06

Similar Documents

Publication Publication Date Title
MY109743A (en) Pyrimidine derivatives.
PT87329A (pt) Process for preparing a stabilized hydrogen peroxide solution for disinfecting contact lens
CA2331873A1 (en) Fumagillol derivatives and processes for preparing the same
HUP9802814A2 (hu) Szelektív béta3 adrenergiás agonista hatású vegyületek, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
WO2007105253B1 (en) PREPARATION OF (1-OXA- OR l-THIA-)3- CEPHEM DERIVATIVES
CO5080803A1 (es) Proceso de preparacion de 4-substituido-1h-indol-3-glioxami- das
NZ503399A (en) Phthalazine derivatives, a process for their production; and remedies for erectile dysfunction and female sexual disfunction or dysmenorrhea
IE781926L (en) Peptides analgesics
CO5021230A1 (es) Proceso de preparacion de 4-substituido-1h-indol-3- glioxamidas
IL71201A0 (en) Bactericidal compositions containing quinolonecarboxylic acid derivatives and certain such novel compounds
DE3476066D1 (en) Salt free phosphobetaines
ES8900129A1 (es) Procedimiento de producir agentes terapeuticos y profilacticos para ulceras pepticas
DE69405300D1 (de) Verfahren zur Herstellung von Cephalosporinverbindungen aus reaktiven organischen Säurederivaten
ES446126A1 (es) Procedimiento para preparar 2-(fenoxialquiltio) imidazoles.
US20180230170A1 (en) Protected organoboronic acids with tunable reactivity, and methods of use thereof
ATE354540T1 (de) Nonaboratzusammensetzung und ihre herstellung
ES2004809A6 (es) Procedimiento de obtencion de nuevas 1-(2-(fenilmetil)fenil)piperazinas
EP0223512A3 (en) 2-pyridylacetic acid derivative, preparation process thereof and pharmaceutical composition containing the same
ECSP992922A (es) Proceso para preparar 4- sustituidas- 1h- indola-3- glioxamidas
US5053500A (en) Intermediates for the preparation of beta-lactam antibiotics
GB997166A (en) N-phenylpiperazine derivatives
ECSP992921A (es) Procedimeinto para la preparacion de 4- sustituido-1h-indol - 3 - glioxamidas
GB964233A (en) Derivatives of 5-nitro-2-furylnitrile
PT86499B (pt) Processo para o fabrico de produtos ceramicos modelados por reproducao da forma de um molde consumivel
EP1136476A3 (en) Process for the preparation of 5,5&#39;-bi-1H-Tetrazolediammonium salts using hydrazine hydrate and dicyan as starting materials